Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
Padmapriyadarsini C, Oswal VS, Jain CD, Mariappan MV, Singla N, Kumar S, Daniel BD, Dave JD, Vadgama P, Ramraj B, Kant S, Bhatnagar AK, Shanmugam S, Paul D, Bharathi J, Palav M, Shah NV, Santhanakrishnan R, Dewan RK, Shekh N, Rathinam P, Sisara AB, Mankar SD, Bajpai J, Mittal U, Chauhan S, Kumar R, Parmar M, Mattoo SK, Jaju J; modified BPaL (mBPaL) Study Team. Padmapriyadarsini C, et al. Among authors: oswal vs. Clin Infect Dis. 2024 Dec 17;79(6):1375-1385. doi: 10.1093/cid/ciae388. Clin Infect Dis. 2024. PMID: 39194339 Clinical Trial.
Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study.
Khan S, Silsarma A, Mahajan R, Khan S, Davuluri P, Sutar N, Iyer A, Mankar S, Oswal V, Puri V, Shah D, Chavan V, Spencer H, Isaakidis P. Khan S, et al. J Clin Tuberc Other Mycobact Dis. 2024 Oct 12;37:100481. doi: 10.1016/j.jctube.2024.100481. eCollection 2024 Dec. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 39497757 Free PMC article.
Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from India.
Agibothu Kupparam HK, Shah I, Chandrasekaran P, Mane S, Sharma S, Thangavelu BR, Vilvamani S, Annavi V, Mahalingam SM, Thiruvengadam K, Navaneethapandian PG, Gandhi S, Poojari V, Nalwalla Z, Oswal V, Giridharan P, Babu SB, Rathinam S, Frederick A, Mankar S, Jeyakumar SM. Agibothu Kupparam HK, et al. J Antimicrob Chemother. 2024 Nov 4;79(11):2939-2947. doi: 10.1093/jac/dkae311. J Antimicrob Chemother. 2024. PMID: 39308327
Tuberculosis in Chronic Kidney Disease.
Vora A, Oswal V. Vora A, et al. J Assoc Physicians India. 2020 Feb;68(2):11-14. J Assoc Physicians India. 2020. PMID: 32009354 No abstract available.
Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
Dhakulkar S, Das M, Sutar N, Oswal V, Shah D, Ravi S, Vengurlekar D, Chavan V, Rebello L, Meneguim AC, Iyer A, Mansoor H, Kalon S, Acharya S, Ferlazzo G, Isaakidis P, Thakur HP. Dhakulkar S, et al. PLoS One. 2021 Feb 18;16(2):e0246639. doi: 10.1371/journal.pone.0246639. eCollection 2021. PLoS One. 2021. PMID: 33600431 Free PMC article.
Clinical utility of target-based next-generation sequencing for drug-resistant TB.
Mansoor H, Hirani N, Chavan V, Das M, Sharma J, Bharati M, Oswal V, Iyer A, Morales M, Joshi A, Ferlazzo G, Isaakidis P, Ndlovu Z, England K. Mansoor H, et al. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):41-48. doi: 10.5588/ijtld.22.0138. Int J Tuberc Lung Dis. 2023. PMID: 36853141 Free PMC article.
Adapting TB services during the COVID-19 pandemic in Mumbai, India.
Meneguim AC, Rebello L, Das M, Ravi S, Mathur T, Mankar S, Kharate S, Tipre P, Oswal V, Iyer A, Mansoor H, Kalon S, Garone D, Ferlazzo G, Isaakidis P. Meneguim AC, et al. Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1119-1121. doi: 10.5588/ijtld.20.0537. Int J Tuberc Lung Dis. 2020. PMID: 33126951 No abstract available.